Myeloproliferative Neoplasms (MPN) and COVID-19 (MPN-COVID)
Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
This observational or N/A phase trial investigates COVID and Myeloproliferative Neoplasm and is currently completed. FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS leads this study, which shows 12 recorded versions since 2020 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
12 versions recorded-
Oct 2025 — Present [monthly]
Completed
Status: Unknown → Completed
-
Sep 2025 — Oct 2025 [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
May 2024 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 7 earlier versions
-
May 2022 — May 2024 [monthly]
Recruiting
-
Dec 2021 — May 2022 [monthly]
Recruiting
-
Mar 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
Aug 2020 — Jan 2021 [monthly]
Recruiting
-
Jul 2020 — Aug 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2020 — Jul 2020 [monthly]
Not Yet Recruiting
First recorded
May 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
- Gruppo Italiano Malattie EMatologiche dell'Adulto
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aachen, Germany , Albacete, Spain , Alcalá de Henares, Spain , Alessandria, Italy , Alicante, Spain , Badalona, Spain , Barcelona, Spain , Bergamo, Italy , Bologna, Italy , Brescia, Italy and 24 more locations